Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Positive safety and efficacy outcome of the COVID-19 clinical Phase I/II study for the ABNCoV2 vaccine

Hørsholm, Denmark, August 09, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that COUGH-1, the COVID-19 Phase I/II clinical trial to evaluate the ABNCoV2 vaccine, as headline results has met its safety and efficacy endpoints with excellent virus neutralization levels of up to 12 times higher compared to the levels achieved after COVID-19 infection. This is significantly higher than the virus neutralization levels reported for leading mRNA COVID-19 vaccines reaching only up to 4.1 times higher than the levels achieved after COVID-19

Swedavia’s traffic statistics for July 2021

In July, more than 1.4 million passengers flew via Swedavia’s ten airports, which corresponds to a decrease of over 60 per cent compared to the same period before the pandemic, July 2019. However, the demand for flights continues to recover with more people being given the opportunity to travel as societies open up and vaccination programmes are rolled out. Meanwhile, the EU’s new digital Covid travel certificate creates conditions for smoother travel if control procedures can be further harmonised in the EU. “Air traffic continues to recover and in July, for the first time since

Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2021 results, Wednesday 18 August

Oslo, Norway, 9 August 2021 - Targovax ASA (OSE: TRVX) will announce its second quarter and first half 2021 results on Wednesday 18 August 2021. An online presentation by Targovax's management to investors, analysts and the press will take place at 10:00 am CET.The results report and the presentation will be available at www.targovax.com  in the Investors section from 07:00 am CET. Presentation As a consequence of the Corona situation, there will only be a virtual presentation of the results with a live webcast 18 August at 10.00 am CET.

Brighter carries out a private placement of 39.7 MSEK

The Board of Directors of Brighter has, under the authorization from the AGM of 2020, decided on a new share issue of a total of 39.7 MSEK. Payment will be made in cash. The amount of cash received will be used in full to repay previous loans from these lenders and the right to participate in the issue is only given to the lenders. The reasons for the deviation from the shareholders' preferential rights are to strengthen the company's financial position, which the issue is deemed to entail.   Issue terms:  · 10% discount on the lowest volume-weighted average price of the share

Veoneer to Engage in Discussions with Qualcomm

Stockholm, Sweden, August 8, 2021 – The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), today announced that Veoneer’s board of directors has determined that Qualcomm’s proposal to acquire Veoneer (the “Qualcomm Proposal”) would reasonably be expected to result in a “Superior Proposal”, as defined under the terms of Veoneer’s merger agreement with Magna (the “Merger Agreement”). As a result of the Board’s determination, Veoneer may under the terms of the Merger Agreement engage in discussions with Qualcomm based on the Qualcomm Proposal and Veoneer intends to do

Vo2 Cap Holding AB (publ) has been approved for listing on Nasdaq First North Growth Market (Cision)

Current company Curando Nordic AB (publ) ("Curando / Bolaget") which is planned to be renamed to Vo2 Cap Holding AB (publ) has applied for and received a conditional approval for trading on the Nasdaq First North Growth Market (“Nasdaq”).INFORMATION IN THIS PRESS RELEASE IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA, SINGAPORE, or any other jurisdiction where such publication or distribution would violate applicable laws or regulations. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS

DecideAct signs first contract in the Danish education sector.

DecideAct signs a contract with ZBC (Zealand Business College), one of Denmark's largest vocational schools and the largest high school on Zealand. ZBC will use the solution to coordinate its overall efforts across eight cities in relation to the UN Sustainable Development Goals.DecideAct A/S [ACT] Company Announcement No. 18-2021: About DecideAct A/S [ACT]   DecideAct has today signed a contract with the first educational institution in Denmark. ZBC is among Denmark's largest vocational schools with HHX and HTX high schools as well as 10th grade in eight cities on Zealand. ZBC

Etrion Releases Second Quarter 2021 Results

August 6, 2021, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) (TSX: ETX) (OMX: ETX) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and six months ended June 30, 2021. Q2-21 HIGHLIGHTS Corporate · On May 31, 2021, the Company completed the sale of its interests in the 45 MW Niigata solar project to a consortium led by Renewable Japan Co. Ltd for gross proceeds of JPY6.3 billion (approximately US$57.7 million).

The exercise price for the warrants of series TO1 in Pharmacolog i Uppsala AB (publ) has been determined to SEK 8,06 per share

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.Pharmacolog i Uppsala AB (publ) (“Pharmacolog” or the “Company”) completed an issue of warrants of series TO1 during the second quarter of 2020. Each warrant entitles the holder to

Norway Royal Salmon ASA (NRS): Acceptances received under mandatory offer to acquire all shares in Norway Royal Salmon ASA

Reference is made to the mandatory offer (the "Offer") from NTS ASA (the "Offeror") to acquire all shares in Norway Royal Salmon ASA ("NRS" or the "Company") pursuant to an offer document dated 16. July 2021, at an offer price of NOK 209 per share and with an offer period from 19 July 2021 to 16 August 2021 at 16:30 CEST (subject to extension) (the "Offer"). On 6 August 2021, the Offeror received acceptance under the Offer for 260 shares. The Offeror has during the Offer Period received acceptances for in total 3,618 shares in NRS. In addition, NTS has acquired 601,871 shares in NRS over

Elkem ASA - Buyback of shares

Oslo, 6 August 2021 Please see below information about transactions made under the share buyback programme for Elkem ASA. · Date on which the buyback programme was announced: 20 July 2021 · The duration of the buyback programme: 20 July 2021 to 26 September 2021 · Size of the buyback programme: Up to 10,000,000 shares From 31 July 2021 until 6 August 2021, Elkem ASA has purchased a total of 1,625,000 own shares at the Oslo Stock Exchange at an average price of NOK 33.0591 per share. Aggregated overview of transactions per day: Date Aggregated Weighted

Notice to attend extraordinary general meeting in Zutec Holding AB (publ)

The shareholders of Zutec Holding AB (publ), reg.no 559136-0317 (the "Company") are hereby summoned to an Extraordinary General Meeting (the "Meeting") on Tuesday 7 September 2021. Due to the risk of spreading of Covid-19 and the authorities' regulations and advice on avoiding meetings, the Board of directors has decided, on the basis of temporary regulations, that the Meeting shall be conducted without physical presence by shareholders exercising their voting rights only by postal voting. PARTICIPATION A Shareholder wishing to attend the Meeting shall: · be recorded in the

#21-263 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-262 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Eastnine publishes bond prospectus and applies for admission to trading of its green bonds at Nasdaq Stockholm

On 30 June 2021, Eastnine AB (publ) (“Eastnine” or the “Company”) announced that the Company had successfully issued senior unsecured green bonds in the amount of EUR 45 million, under a framework of EUR 100 million (the “Bonds”). The Bonds carry a floating rate interest of 3 months EURIBOR plus 500 basis points per annum and mature in July 2024. According to the terms and conditions for the Bonds, the Company has undertaken to apply for admission to trading of the Bonds on the sustainable bond list of Nasdaq Stockholm, for which purpose Eastnine has prepared a listing prospectus which

Graduate artist lauded as ‘one to watch’ by industry experts

An award-winning artist says coming to Staffordshire University through Clearing was one of the ‘best decisions’ of her life.Jioni Warner originally applied to study Sports Therapy but after having seconds thought she decided to follow her lifelong passion for art through Clearing. She explained: “It was a last-minute decision to change but it was one of the best decisions I’ve ever made! Applying through Clearing was really easy and I got a quick response from Staffordshire Uni.” After enrolling on the Art and Design foundation degree, Jioni progressed onto the BA (Hons) Fine Art (

ABAX removes 1,000,000 plastic bottles from the environment

In developing nations, where waste management is inadequate, devastating effects from plastic pollution are present. ABAX has joined Empower to help developing countries establish effective recycling solutions and expand our environmental impact portfolio. From oceanic waste and landfills to plastic burning, the effects of ineffective plastic management systems are rife. To make matters worse, developed nations send excess waste to developing nations for processing when these countries are ill-equipped to deal with the burden.  It's a problem that has become so big it's found

Read original

Optomed Plc - Managers' transactions - Guo

Optomed Plc Managers' transactions  6 August 2021 at 13.15, Helsinki Optomed Plc - Managers' transactions - Guo ____________________________________________ Person subject to the notification requirement Name: Guo, Xisi Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20210806081326_9 ____________________________________________ Transaction date: 2021-08-06 Venue not applicable Instrument type: SHARE ISIN: FI4000410881 Nature of

Optomed Plc - Managers' transactions - Salonen

Optomed Plc Managers' transactions  6 August 2021 at 13.15, Helsinki Optomed Plc - Managers' transactions - Salonen ____________________________________________ Person subject to the notification requirement Name: Salonen, Petri Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20210806081326_5 ____________________________________________ Transaction date: 2021-08-06 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Optomed Plc - Managers' transactions - Tauriainen

Optomed Plc Managers' transactions  6 August 2021 at 13.15, Helsinki Optomed Plc - Managers' transactions - Tauriainen ____________________________________________ Person subject to the notification requirement Name: Tauriainen, Reijo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20210806081326_7 ____________________________________________ Transaction date: 2021-08-06 Venue not applicable Instrument type: SHARE ISIN:

Optomed Plc - Managers' transactions - Tenstam

Optomed Plc Managers' transactions  6 August 2021 at 13.15, Helsinki Optomed Plc - Managers' transactions - Tenstam ____________________________________________ Person subject to the notification requirement Name: Tenstam, Anna Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20210806081326_8 ____________________________________________ Transaction date: 2021-08-06 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Optomed Plc - Managers' transactions - Mäkinen

Optomed Plc Managers' transactions  6 August 2021 at 13.15, Helsinki Optomed Plc - Managers' transactions - Mäkinen ____________________________________________ Person subject to the notification requirement Name: Mäkinen, Seppo Position: Member of the Board/Deputy member Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20210806081326_6 ____________________________________________ Transaction date: 2021-08-06 Venue not applicable Instrument type: SHARE ISIN: FI4000410881

Vestas secures 126 MW EnVentus order in Finland

News release from Vestas Northern & Central EuropeHamburg, 6 August 2021 Vestas has received a 126 MW order from Taaleri Energia for the Isoneva project in Finland, adding to the more than 1.8 GW in firm orders already received in Finland for the EnVentus platform. The order includes supply, installation 21 V162-6.0 MW turbines from Vestas’ EnVentus platform. This order follows the 126 MW order received from Taaleri Energia for the Murtotuuli project in the second quarter of 2021. Vestas will provide service for the Isoneva project through a long-term Active Output Management

Lehto Group Plc will publish the Half Year Financial Report for 2021 on 12 August 2021

Invitation for investors and mediaLehto Group Plc6 August 2021 at 13.00 (EET)Lehto Group Plc will publish the Half Year Financial Report for 2021 on 12 August 2021 at 7.30 a.m. (EET) The report in Finnish and English will be available on Lehto’s website. Conference online Lehto Group will hold a conference on the Half Year Financial Report for the media, analysts and investors on Thursday 12 August 2021 at 9:30 a.m. (EET). Due to the prevailing corona situation, the event will only be held online. The conference can also be followed as a live webcast on Lehto’s website at lehto.fi/

There are no items matching the current filter
There are no more items matching the current filter
Back to top